Gooch & Housego (GHH) Trading update summary
Event summary combining transcript, slides, and related documents.
Trading update summary
11 Mar, 2026Trading performance
Revenue for the second half is delayed due to supplier and customer delivery issues, leading to expected full-year adjusted PBT being about £1.5m lower than previously forecast.
Order book grew to £116.8m at end of July 2024, up from £115.8m at end of March 2024.
Bank borrowings reduced to £18.0m and total net debt to £25.5m by end of July 2024.
Strategic initiatives and integration
Integration of Artemis and GS Optics is progressing well, enhancing system solutions and opening new revenue streams.
Outsourcing of hi-reliability fused fibre couplers is complete, with more products being qualified for outsourced production.
Phase one investment in new R&D and engineering at the Rochester NY campus will finish by year-end, with strong customer interest.
Continuous improvement activities are prioritized to achieve operational efficiency, especially as market recovery is anticipated.
Steps are being taken to address cost base in response to low-cost competition in the medical laser market.
Outlook
Preparing for recovery in industrial laser and semiconductor markets in early 2025, with expectations for FY2025 unchanged.
Healthy order book and strong pipeline provide confidence for next year.
Latest events from Gooch & Housego
- Revenue up, profit down; strong order book and A&D/Life Sciences offset industrial weakness.GHH
H2 202411 Mar 2026 - Revenue and profit fell, but improved margins and a strong order book support a positive outlook.GHH
H1 202411 Mar 2026 - Acquisition creates a U.S. optical systems hub, boosting defense capabilities and growth potential.GHH
M&A announcement11 Mar 2026 - Revenue and profit surged, led by A&D and Life Sciences, with strong order cover for FY2025.GHH
H1 202511 Mar 2026 - Double-digit revenue and profit growth driven by A&D and acquisitions, with a record order book.GHH
H2 202511 Mar 2026 - Solid FY2024 results and acquisitions set the stage for growth in Life Sciences and Defence.GHH
Investor presentation11 Mar 2026 - Order book grew to £126.4M, driven by innovation, acquisitions, and operational improvements.GHH
AGM 2025 presentation11 Mar 2026 - Double-digit revenue growth and record order intake driven by A&D and new technology focus.GHH
AGM 2026 presentation11 Mar 2026 - Strong second half trading and robust cash generation position the group for next year's recovery.GHH
Trading update11 Mar 2026